Giardiasis: Diagnosis, Pathogenesis and Treatment

  • Home
  • Giardiasis: Diagnosis, Pathogenesis and Treatment

Giardiasis: Diagnosis, Pathogenesis and Treatment

1Ola Abdul Shaheed Naser, 2Mona Adel Ismai, 3Wijdan Dhaidan Shnain Al-Abbas, 4Ali A. Al-fahham
1Department of pathological analyses, College of Science, University of Basrah, Iraq
2Technical Institute / Kufa, Al-Furat Al-Awsat Technical University, Iraq
3Department of Basic Science, Faculty of Nursing, University of Kufa, Iraq
4Corresponding Author, Faculty of Nursing, University of Kufa, Iraq


ABSTRACT:

Giardiasis has become a worldwide health problem and it is the most frequent cause of diarrhea in both pediatric and adults’ patients. Ingestion of cysts directly or indirectly via the fecal-oral route is the main mode of transmission. The laboratory diagnosis of Giardia spp. primarily relies on identifying microscopic cysts or trophozoites in stool samples. Additionally, various immunological assays and molecular methods are available for diagnosing giardiasis. The infection stimulates the immune system, leading to increased production of immunoglobulins and cytokines. Generally, metronidazole, nitazoxanide and tinidazole are the preferred drugs for treating giardiasis. This review summarizes existing literature on giardiasis, covering diagnosis, pathogenesis, management, and treatment.

  

REFERENCES :

1) Adam R. D. (2001). Biology of Giardia lamblia. Clinical microbiology reviews, 14(3), 447–475. https://doi.org/10.1128/CMR.14.3.447-475.2001
2) Dizdar, V., Gilja, O. H., & Hausken, T. (2007). Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterology and motility, 19(12), 977–982. https://doi.org/10.1111/j.1365-2982.2007.00988.x
3) Dunn N, Juergens AL. Giardiasis. (2024) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK513239/
4) Escobedo, A. A., Almirall, P., Chirino, E., Pacheco, F., Duque, A., & Avila, I. (2018). Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series. Le infezioni in medicina, 26(4), 379–384.
5) Hadi, W. S., Salman, R. S., Al-Fahham, A. A., Faryad Khan, M. U., Kadir, S., Laft, M. H., Saeed, B. Q., Kadhum, W. R., Jalil, A. T., & Kadhim, M. M. (2022). Evaluation of IL-17 and IL-35 in patients with giardiasis in Thi-Qar province, Iraq. Journal of medicine and life, 15(9), 1096–1099. https://doi.org/10.25122/jml-2021-0328
6) Halliez, M. C., & Buret, A. G. (2013). Extra-intestinal and long term consequences of Giardia duodenalis infections. World journal of gastroenterology, 19(47), 8974–8985. https://doi.org/10.3748/wjg.v19.i47.8974
7) Hanevik, K., Hausken, T., Morken, M. H., Strand, E. A., Mørch, K., Coll, P., Helgeland, L., & Langeland, N. (2007). Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. The Journal of infection, 55(6), 524–530. https://doi.org/10.1016/j.jinf.2007.09.004
8) Heyworth M. F. (2014). Diagnostic testing for Giardia infections. Transactions of the Royal Society of Tropical Medicine and Hygiene, 108(3), 123–125. https://doi.org/10.1093/trstmh/tru005
9) Hooshyar, H., Rostamkhani, P., Arbabi, M., & Delavari, M. (2019). Giardia lamblia infection: review of current diagnostic strategies. Gastroenterology and hepatology from bed to bench, 12(1), 3–12.
10) Leung, A. K. C., Leung, A. A. M., Wong, A. H. C., Sergi, C. M., & Kam, J. K. M. (2019). Giardiasis: An Overview. Recent patents on inflammation & allergy drug discovery, 13(2), 134–143. https://doi.org/10.2174/1872213X13666190618124901
11) Ryan, U., & Cacciò, S. M. (2013). Zoonotic potential of Giardia. International journal for parasitology, 43(12-13), 943–956. https://doi.org/10.1016/j.ijpara.2013.06.001
12) Singer S. M. (2015). Control of Giardiasis by Interleukin-17 in Humans and Mice–Are the Questions All Answered?. Clinical and vaccine immunology : CVI, 23(1), 2–5. https://doi.org/10.1128/CVI.00648-15
13) Singer SM. (2016). Control of Giardiasis by Interleukin-17 in Humans and Mice—Are the Questions All Answered?. Clin Vaccine Immunol 23:.
14) https://doi.org/10.1128/CVI.00648-15
15) Singer, S. M., & Nash, T. E. (2000). T-cell-dependent control of acute Giardia lamblia infections in mice. Infection and immunity, 68(1), 170–175. https://doi.org/10.1128/IAI.68.1.170-175.2000
16) Smith HV, Mank TG. (2011) Diagnosis of human Giardiasis. In: Lujan HD, Svard S, Eds , editors. Giardia a model organism. New York: Springer-Verlag: 353–74
17) Soares, R., & Tasca, T. (2016). Giardiasis: an update review on sensitivity and specificity of methods for laboratorial diagnosis. Journal of microbiological methods, 129, 98–102. https://doi.org/10.1016/j.mimet.2016.08.017
18) Youn, S., Kabir, M., Haque, R., & Petri, W. A., Jr (2009). Evaluation of a screening test for detection of giardia and cryptosporidium parasites. Journal of clinical microbiology, 47(2), 451–452. https://doi.org/10.1128/JCM.01736-08
19) Zajaczkowski, P., Mazumdar, S., Conaty, S., Ellis, J. T., & Fletcher-Lartey, S. M. (2018). Epidemiology and associated risk factors of giardiasis in a peri-urban setting in New South Wales Australia. Epidemiology and infection, 147, e15. https://doi.org/10.1017/S0950268818002637

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *